Ente, Rosemarie S.
HRN: 10-57-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFTRIAXONE 1G (VIAL)
05/30/2022
06/06/2022
IV
2g
Q 24H
Multiple Abrasions, T/C Blunt Abdominal Trauma
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes